Nautilus Biotechnology, Inc. (NAUT)
2.74
+0.09
(+3.40%)
USD |
NASDAQ |
Mar 18, 16:00
2.74
0.00 (0.00%)
Pre-Market: 20:00
Nautilus Biotechnology Market Cap : 346.79M for March 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nephros, Inc. | 32.46M |
| Pyxis Oncology, Inc. | 95.26M |
| ProKidney Corp. | 294.41M |
| Neumora Therapeutics, Inc. | 441.12M |
| ACADIA Pharmaceuticals, Inc. | 3.464B |
Market Cap Related Metrics
| Price to Book Value | 2.209 |
| Price | 2.74 |
| Earnings Yield | -17.05% |